Abstract
Nineteen patients were treated with high dose chemotherapy followed by an autologous bone marrow transplantation. The chemotherapy regimen was an association of BCNU, procarbazine, etoposide, melphalan. Six patients had a progressive disease; 4 short-term complete remissions were observed. In 13 responding patients, 6 maintained complete remissions were noted.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bone Marrow Transplantation*
-
Carcinoma, Small Cell / drug therapy
-
Carcinoma, Small Cell / therapy*
-
Carmustine / administration & dosage
-
Combined Modality Therapy
-
Etoposide / administration & dosage
-
Humans
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / therapy*
-
Melphalan / administration & dosage
-
Procarbazine / administration & dosage
Substances
-
Procarbazine
-
Etoposide
-
Melphalan
-
Carmustine